The G7 continuous glucose monitoring system has been making waves in the medical world with its latest announcement. According to the company, the G7 system will have a remarkable 15.5-day wear time and last 15% longer than its predecessor, the Dexcom G7. This breakthrough in technology is set to revolutionize the management of diabetes and provide patients with a more convenient and reliable option for continuous glucose monitoring.
For those who may not be familiar, the G7 continuous glucose monitoring system is a small device that is placed under the skin to continuously monitor glucose levels in the body. It eliminates the need for manual blood sugar checks, making it a game-changer for people living with diabetes. The device works by sending real-time glucose readings to a receiver or a smartphone app, allowing patients to track their blood sugar levels and make necessary adjustments to their treatment.
The G7 system is the brainchild of Dexcom, a leading company in the field of continuous glucose monitoring. With its track record of innovative and reliable products, the G7 system has been highly anticipated by both patients and healthcare professionals. And with the company’s latest announcement, it seems that the wait was well worth it.
The G7 system’s 15.5-day wear time is a significant improvement from its predecessor, the Dexcom G6, which has a wear time of 10 days. This means that patients will now be able to wear the device for almost two weeks before needing to replace it. This is a huge advantage for individuals who lead busy lives and may not have the time to change their device every week. Moreover, this extended wear time will also reduce the cost of the device as patients will need fewer supplies.
But that’s not all, the G7 system will also last 15% longer than the Dexcom G6, making it the longest-lasting continuous glucose monitoring system in the market. This is a significant improvement for patients who have struggled with the durability of previous devices. The G7 system’s longer lifespan will not only save patients money but also provide them with peace of mind knowing that they have a reliable device that can withstand their daily activities.
The G7 system also boasts of other features that make it stand out from its competitors. It is much smaller and slimmer than previous models, making it more discreet and comfortable to wear. It also has an improved adhesive that ensures the device stays in place even during physical activities. Additionally, the G7 system is water-resistant, allowing patients to wear it while showering or swimming.
The G7 system’s impressive wear time and durability are made possible by its advanced technology. The device uses a new sensor that is smaller and more efficient, allowing it to last longer while still providing accurate glucose readings. This technology is a significant step forward in the continuous glucose monitoring field and will undoubtedly improve the lives of people living with diabetes.
The G7 system’s longer wear time and durability have been met with a positive response from the diabetes community. Patients are eagerly awaiting the device’s release, and healthcare professionals are excited to offer their patients a more convenient and reliable option for continuous glucose monitoring. The G7 system is expected to launch in late 2021 and is set to become the go-to device for diabetes management.
In conclusion, the G7 continuous glucose monitoring system’s 15.5-day wear time and 15% longer lifespan are groundbreaking advancements in diabetes technology. This device has the potential to change the lives of people living with diabetes, providing them with a more convenient and reliable option for continuous glucose monitoring. With its advanced technology and impressive features, the G7 system is set to make a significant impact in the management of diabetes.
